Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinical deep-dive into suvorexant withdrawal, rebound insomnia, and discontinuation symptoms, with trial data, FDA label guidance, and physician-reviewed protocols.
Read clinical reviewA clinical deep-dive into delayed-onset side effects of Belsomra (suvorexant), including next-day somnolence, sleep paralysis, complex sleep behaviors, and withdrawal effects, with data from FDA labeling, FAERS, and published trials.
Read clinical reviewA detailed breakdown of suvorexant (Belsomra) adverse event rates drawn from Phase 3 trials, the FDA prescribing label, FAERS reports, and post-marketing literature, with exact percentages and clinical context.
Read clinical reviewA physician-reviewed guide to Belsomra (suvorexant) side effects, including rare adverse events, potentially long-lasting effects, FAERS data, and clinical trial findings with primary-source citations.
Read clinical reviewA clinically detailed review of rare but serious adverse events linked to Belsomra (suvorexant), including sleep paralysis, complex sleep behaviors, suicidal ideation, and more. Backed by trial data, FDA label language, and FAERS reports.
Read clinical reviewA clinician-reviewed breakdown of Belsomra (suvorexant) adverse events by severity level, patient population, dose, and comorbidity profile. Includes trial data, FAERS signals, and phenotype-specific risk tables.
Read clinical review